--- title: "3D Medicines (1244) stock listing, news and investor profile" url: "https://aibio.space/companies/3d-medicines/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "3D Medicines, Inc. (HKEX: 1244), China. The directory classifies it as Pharmaceuticals: Major." --- 1244 3D Medicines, Inc. HKEX · China # 3D Medicines (1244) news 3D Medicines, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1244, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest 3D Medicines news We have not published a story on 3D Medicines yet. When there is news, it will appear here. ## 3D Medicines at a glance - **Ticker**: 1244 - **Listing**: HKEX - **Country**: China ### Related companies - [Zhejiang Huahai Pharmaceutical Co.](https://aibio.space/companies/zhejiang-huahai-pharmaceutical/) SSE: 600521 - [BrightGene Bio-Medical Technology Co.](https://aibio.space/companies/brightgene-bio-medical-technology/) SSE: 688166 - [Jiangsu Bioperfectus Technologies Co.](https://aibio.space/companies/jiangsu-bioperfectus-technologies/) SSE: 688399 - [Tianjin Lisheng Pharmaceutical Co.](https://aibio.space/companies/tianjin-lisheng-pharmaceutical/) SZSE: 002393 - [Jinyu Bio-Technology Co.](https://aibio.space/companies/jinyu-bio-technology/) SSE: 600201 - [Suzhou Zelgen Biopharmaceuticals Co.](https://aibio.space/companies/suzhou-zelgen-biopharmaceuticals/) SSE: 688266 - [Zhejiang Anglikang Pharmaceutical Co.](https://aibio.space/companies/zhejiang-anglikang-pharmaceutical/) SZSE: 002940 - [Zhuhai Rundu Pharmaceutical Co.](https://aibio.space/companies/zhuhai-rundu-pharmaceutical/) SZSE: 002923 ### Also on HKEX - [Hua Medicine](https://aibio.space/companies/hua-medicine/) 2552 - [Innovent Biologics](https://aibio.space/companies/innovent-biologics/) 1801 - [Sino Biopharmaceutical](https://aibio.space/companies/sino-biopharmaceutical/) 1177 - [ImmuneOnco Biopharmaceuticals (Shanghai)](https://aibio.space/companies/immuneonco-biopharmaceuticals-shanghai/) 1541 - [Zhaoke Ophthalmology](https://aibio.space/companies/zhaoke-ophthalmology/) 6622 - [Consun Pharmaceutical Group](https://aibio.space/companies/consun-pharmaceutical/) 1681 ## Questions about 3D Medicines What is the ticker symbol of 3D Medicines? 3D Medicines, Inc. trades under the ticker 1244 on HKEX. Where is 3D Medicines listed? 3D Medicines, Inc. is listed on HKEX. Which country or territory is 3D Medicines listed under? Our directory records 3D Medicines, Inc. under China. What does 3D Medicines do? Our directory classifies 3D Medicines, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of 3D Medicines? The ISIN recorded for 3D Medicines, Inc. is KYG8872R1011. Does aibio.space cover 3D Medicines? aibio.space lists 3D Medicines, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to 3D Medicines? Companies in our directory listed in the same country and business area as 3D Medicines: Zhejiang Huahai Pharmaceutical Co., BrightGene Bio-Medical Technology Co., Jiangsu Bioperfectus Technologies Co., Tianjin Lisheng Pharmaceutical Co., Jinyu Bio-Technology Co., Suzhou Zelgen Biopharmaceuticals Co.. ## Investor discussion: 3D Medicines Members talk about 3D Medicines (1244). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at 3D Medicines, newest first. Each line links the filing it comes from. 1. 2026-09-17 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0917/2026091700807.pdf) 2. 2026-07-27 Legal Legal proceedings: INSIDE INFORMATION ANNOUNCEMENT ON THE ARBITRATION PROCEEDINGS AGAINST SELLAS LIFE SCIENCES GROUP, INC.. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0727/2026072701401.pdf) 3. 2026-06-05 Financings Share or debt issue: GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500529.pdf) 4. 2026-04-01 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION; AND CLARIFICATION ANNOUNCEMENT ON THE ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0401/2026040100871.pdf) 5. 2025-07-14 Mergers Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE STRATEGIC COOPERATION AGREEMENT AND UPDATES ON CIVIL PROCEEDINGS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0714/2025071401166.pdf) 6. 2025-07-02 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION CONNECTED TRANSACTION AT SUBSIDIARY LEVEL IN RESPECT OF THE STRATEGIC COOPERATION AGREEMENT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0702/2025070200101.pdf) 7. 2025-06-05 Financings Share or debt issue: GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0605/2025060502113.pdf) ## Press releases Headlines of 3D Medicines's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-02 HKEXnews [CHANGE OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1002/2026100200807.pdf) 2. 2026-09-17 HKEXnews [DISCLOSEABLE TRANSACTION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0917/2026091700807.pdf) 3. 2026-08-31 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083103027.pdf) 4. 2026-08-18 HKEXnews [VOLUNTARY ANNOUNCEMENT UPDATE ON COMPLETION OF ENFORCEMENT OF THE ARBITRAL AWARD WITH SELLAS LIFE SCIENCES GROUP, INC.](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0818/2026081800301.pdf) 5. 2026-08-07 HKEXnews [RESIGNATION OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0807/2026080701489.pdf) 6. 2026-08-04 HKEXnews [CHANGE OF PROCESS AGENT AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0804/2026080402299.pdf) 7. 2026-07-27 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT ON THE ARBITRATION PROCEEDINGS AGAINST SELLAS LIFE SCIENCES GROUP, INC.](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0727/2026072701401.pdf) 8. 2026-06-30 HKEXnews [UPDATE ON THE QUALIFICATION OF COMPANY SECRETARY; RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063002793.pdf) 9. 2026-06-30 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063002755.pdf) 10. 2026-06-05 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500545.pdf) 11. 2026-06-05 HKEXnews [GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500529.pdf) 12. 2026-05-27 HKEXnews [VOLUNTARY ANNOUNCEMENT PHASE III STUDY RESULTS OF ENVAFOLIMAB PLUS GEMOX IN FIRST-LINE TREATMENT OF ADVANCED BILIARY TRACT CANCER TO BE OFFICIALLY PRESENTED AT 2026 ASCO ANNUAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0527/2026052700195.pdf) 13. 2026-05-21 HKEXnews [VOLUNTARY ANNOUNCEMENT EARLY COMPLETION OF ENROLLMENT IN THE PHASE III CLINICAL TRIAL OF ENVAFOLIMAB FOR NEOADJUVANT/ADJUVANT TREATMENT OF NON-SMALL CELL LUNG CANCER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052101426.pdf) 14. 2026-04-01 HKEXnews [DISCLOSEABLE TRANSACTION; AND CLARIFICATION ANNOUNCEMENT ON THE ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0401/2026040100871.pdf) 15. 2026-03-31 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0331/2026033104297.pdf) 16. 2026-02-09 HKEXnews [VOLUNTARY ANNOUNCEMENT ENVAFOLIMAB SUPPLEMENTAL APPLICATION FOR CONDITIONAL-TO-REGULAR APPROVAL TRANSITION ACCEPTED BY NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0209/2026020901516.pdf) 17. 2026-01-12 HKEXnews [CHANGE OF CHIEF FINANCIAL OFFICER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0112/2026011201353.pdf) 18. 2026-01-09 HKEXnews [VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR FIRST-LINE TREATMENT OF BILIARY TRACT CANCER OF ENVAFOLIMAB ACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0109/2026010901283.pdf) 19. 2025-12-22 HKEXnews [VOLUNTARY ANNOUNCEMENT ENVAFOLIMAB GRANTED ORPHAN-DRUG DESIGNATION FOR TREATMENT OF GASTRIC CANCER AND GASTRO-ESOPHAGEAL JUNCTION CANCER INDICATIONS](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1222/2025122201624.pdf) 20. 2025-08-29 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0829/2025082903474.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:1244 on TradingView](https://www.tradingview.com/symbols/HKEX-1244/). ## Listing details 3D Medicines, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1244, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: 3D Medicines, Inc. - **Ticker**: 1244 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG8872R1011 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-1244/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/3d-medicines/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "3D Medicines (1244) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/3d-medicines/